François Beaubien, Ph.D., C.F.A., joined Sectoral in 2014 and now serves as a Partner on the NEMO team. He is primarily responsible for managing deal flow and conducting in depth due diligence on private biotech companies. François is a director on the board of Apnimed. François graduated in 2012 from McGill University with a Ph.D. in Neuroscience and in 2013 from UBC in Vancouver with an MBA degree. He obtained his CFA charter in 2018.
6 of 9